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Abstract
Background: In high-income settings, body mass index (BMI) and measures of central
adiposity, such as waist-to-hip ratio (WHR) are associated with cardiometabolic risk, but
evidence from low-income settings, particularly sub-Saharan Africa (SSA), is limited.
We assessed whether there are differences between central and general adiposity in
their associations with fasting glucose, diabetes, systolic and diastolic blood pressures
and hypertension, and whether these associations differ with gender or rural/urban
setting in Malawi.
Methods: We used data from a population-based study of 27 880 Malawian adults aged
18 years, from both rural and urban areas. We used age-standardized z-scores of the
means of BMI and WHR to directly compare their associations with glycaemic and blood
pressure outcomes.
Results: Mean fasting glucose and blood pressure values and odds of hypertension
increased linearly across fifths of BMI and WHR, with stronger associations with BMI. For
both BMI and WHR, the associations with outcomes were stronger in urban versus rural
residents. The association with diabetes was stronger in women than men, whereas for
blood-pressure related outcomes a stronger association was seen in men.
Conclusions: BMI is more strongly associated with cardiometabolic risk in SSA, and
might be a more useful measure than WHR, in this population. The greater positive
association of adiposity with cardiometabolic outcomes in urban residents (where rates
of overweight/obesity are already high) highlights the particular importance of
addressing obesity within urban SSA populations.
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Introduction
Non-communicable diseases (NCD) are replacing infectious
diseases as the leading cause of adult death worldwide,
including in low- and middle-income countries (LMIC).
Being overweight or obese is a major modifiable risk factor
for a wide range of NCDs including cardiovascular disease,
type 2 diabetes mellitus and certain cancers.1 Body mass
index (BMI) is the most commonly used measure for esti-
mating general adiposity and is considered the most reliable
proxy for body fat percentage in population health studies,
in part because of ease of measurement.2
BMI does not distinguish between central or peripheral
fat. Some evidence suggests that centrally distributed
visceral fat and ectopic liver fat are associated with cardio-
metabolic outcomes independently of BMI or total fat
mass.3 Among Western populations, waist circumference
(WC), waist-to-hip ratio (WHR) and waist-to-height ratio
(WHtR) are used as measures of central adiposity and have
been shown to be positively associated with adverse
cardiometabolic outcomes, with the strength of association
similar to that of BMI.1,4–6
However, whether the same is true in sub-Saharan
African (SSA) populations is unclear, because of the lack of
evidence. The extent to which the marked lifestyle and
dietary differences between rural and urban areas of SSA
lead to differences in the associations between adiposity
and cardiometabolic risk is largely unknown, but is rele-
vant to being able to predict the emerging pattern of health
and to develop appropriately tailored interventions aimed
at preventing these outcomes.
We aimed to:
i. determine whether there are differences between BMI
and waist-based (central adiposity) measurements in
their associations with fasting glucose, diabetes, systolic
and diastolic blood pressures (SBP and DBP) and hyper-
tension in an SSA population;
ii. determine whether any of these associations of BMI
and central adiposity with glycaemic or BP outcomes
differ between gender or rural/urban residence.
Methods
Study design, setting and participants
Cross-sectional data from participants in the Malawi
Epidemiology and Intervention Research Unit (MEIRU)
NCD study was used. The methods used to recruit and col-
lect data from these participants were described in detail
previously.7 Briefly, data collection began in June 2013,
and includes a rural and an urban site. The rural area is an
established research site—the Health and Demographic
Surveillance System (HDSS) in southern Karonga
(Northern region)—with a typical rural population.8 An
urban area (Area 25) of Lilongwe, the capital city of
Malawi (Central region), was selected because it included a
broad spectrum of socioeconomic groups in a high-density
area where the Ministry of Health (MoH) was establishing
a chronic care clinic, similar to that in Karonga, to which
we could link our study participants.9
All adults aged 18 years and older, who were usually
resident at a household in either study area and were able
to consent, were eligible and invited to be included in the
study; 29 733 were contacted and 28 891 (97%) were re-
cruited. For this study, we excluded a priori women who
self-reported being pregnant (N¼ 1011) and, for analyses
with fasting glucose and BP treated as continuous measure-
ments, we excluded those on antidiabetic (N¼ 225) or on
antihypertensive (N¼ 1184) medication, respectively. We
also excluded from the analyses of glucose-related out-
comes those who reported not fasting (N¼ 44) and those
with missing glucose data (N¼ 4726). Following these
exclusions, samples ranged from 22 906 to 27 880 for
different outcomes (Figure 1).
Key messages
• BMI, a measure of general adiposity, is more strongly associated with glycaemia and blood pressures than measures
of central adiposity in a large sub-Saharan African population.
• Positive associations of both general and central adiposity with glycaemia and blood pressures are stronger in urban
compared with rural residents, even after adjustment for potential confounders.
• A stronger positive association with adverse cardio-metabolic health in urban areas, where rates of obesity and overweight
are already high, emphasises the importance of obesity interventions within urban sub-Saharan African populations.
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All participants provided informed written consent
and the study was approved by the Malawi National
Health Sciences Research Committee (NHSRC; proto-
col #1072) and London School of Hygiene and Tropical
Medicine (LSHTM) Ethics Committee (protocol #6303).10
Outcome and exposure variables
All questionnaires and measurements (anthropometric and
BP) were collected by trained field workers using standar-
dized protocols (see Supplementary materials for more details
of the standard protocols, available as Supplementary data at
IJE online). Blood samples were taken by phlebotomy-
trained nurses. Electronic data entry (using tablets) at the
point of collection, with pre-programmed ranges and internal
consistency checks, was used. In interviews, participants were
asked about any medications or previous diagnoses.
Hypertension was defined as having either an SBP
140 mmHg or a DBP 90 mmHg or being on antihyper-
tensive medication.10 Participants who self-reported a pre-
vious diagnosis of hypertension (but did not have elevated
BP in our assessments) were treated as if they did not have
hypertension, because it is common for the term to be used
by health care professionals on the basis of a single BP
measurement. In sensitivity analyses, we explored whether
this affected our results by removing these participants
from analyses.
Participants were asked in interviews whether they had
previously been diagnosed with diabetes and about use of
any regular medication. Diabetes was defined as having
any of the following: fasting glucose 7.0 mmol/l, cur-
rently taking antidiabetic medication or a self-report of a
previous diabetes diagnosis.10 We assumed that all diabetic
participants have type 2 diabetes mellitus because it is ac-
countable for over 90% of cases in SSA and because we do
not know at what age the few patients on insulin were
diagnosed or were started on treatment.11,12
Potential confounders
We considered smoking status, alcohol intake, physical ac-
tivity and socioeconomic position (SEP) to be potential
confounders for the associations between adiposity meas-
urements and the various outcomes. Potential confounders
were selected a priori, based on existing evidence regarding
the relations to both adiposity and our outcomes. In re-
sponse to peer reviewer comments, we additionally ad-
justed for the number of live births in women. Data on
these variables were collected using a modified version of
the World Health Organization (WHO) STEPS question-
naire, by fieldworkers who were fluent in local African lan-
guages (as well as English).7 The methods used to measure
and categorize these variables can be found in the
Supplementary materials (available as Supplementary data
at IJE online).
Statistical analyses
All analyses were carried out using STATATM version 14.0
(StataCorp, TX, USA). In order to directly compare the
directions and magnitudes of the associations of BMI, WC,
Figure 1. STROBE flow chart of participant inclusion into each outcome analysis; a21 participants had more than one exclusion criterion; the majority
of excluded participants had missing glucose values (N¼ 4726). b19 participants had more than one exclusion criterion; the majority of excluded par-
ticipants were on medication (N¼ 1184). cSix participants had more than one exclusion criterion; the majority of excluded participants were missing
diabetes values (N¼ 4693).
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WHR and WHtR, internally age-standardized z-scores of
the means were used for each anthropometric measure.
We considered a priori that WHR would be the best
measure of health adiposity distribution, as both a smaller
waist (less central adiposity) and larger hips (greater per-
ipheral adiposity) have been associated with better cardio-
metabolic health.2,4 We also assumed that WHR would be
the measure of central adiposity that was least correlated
with (and therefore distinct from) BMI. We tested this by
examining pairwise partial correlation coefficients for
zBMI, zWHR, zWC and zWHtR in the overall cohort and
stratified by gender and area of residence.
To explore whether associations were linear or not, we
first plotted means (for continuous outcomes) and percent-
ages (for binary outcomes) against z-score fifths of BMI and
WHR. Multiple linear (continuous outcomes) and logistic
(binary outcomes) regression was used to further explore the
associations. We examined the pattern of association by
inspecting the graphs and by running regression analyses
with the z-score fifths of BMI/WHR entered into models as
four indicator variables (five categories) and as a continuous
score of the fifths. We compared the two models and
considered associations to be non-linear if graphs were
monotonic; the linear trend P-value was>0.05 (two-sided)
and P-value for the comparison of the two models<0.05
(two-sided). Per-fifth associations were presented if there
was no strong evidence for a non-linear effect between
zBMI/zWHR with each outcome.
We then adjusted for potential confounding by smoking
status, alcohol intake, physical activity and SEP (wealth). All
regression analyses were undertaken in the overall cohort
and then stratified into four groups: rural women, rural men,
urban women and urban men. Evidence for differences in
associations between these four groups was explored by
examining the stratified results and by testing for interactions
between either gender or area of residence and BMI/WHR
(as a continuous score of z-score fifths) in their associations
with each outcome, using a likelihood ratio test.
In additional sensitivity analyses, we repeated the main
analyses with BMI and WHR age-standardized z-scores
determined within the four area of residence and gender
strata (rather than within the overall cohort), to explore
whether any marked differences in age distribution
between these groups might have influenced our results.
We also repeated the main analyses for the associations of
zWC and zWHtR with each outcome, using the same
analytical approach as described above for zBMI/zWHR.
Results
The distributions of study characteristics, including
missing data for each variable, for the overall cohort and
by gender and area of residence are shown in Table 1.
Urban residents were younger and more likely to be in the
highest fifth of wealth. Smoking was rare, and 93% of the
overall cohort reported never smoking; it was more com-
mon in urban populations. Most participants reported no
alcohol intake in the past year, but there were marked gen-
der differences with few women drinking alcohol and
50% of men drinking at least some in the past year. The
vast majority of all participants (86%) reported high levels
of physical activity, particularly rural women. Of the co-
hort: 13% were hypertensive, with levels highest in urban
men; 2% were diabetic with levels highest in urban resi-
dents; BMI was higher in women than men and in urban
than rural residents; And WHR varied less between groups
and was lowest in urban women.
Among the participants, 17% did not have a fasting glu-
cose measure; levels of missing data were<1% for all other
variables. Thus, the numbers included in analyses with
fasting glucose/diabetes as outcomes are smaller than those
with BP/hypertension as outcomes (Figure 1). A missing
fasting glucose measure was more likely if participants
were male, urban residents, ex-smokers, heavy consumers
of alcohol, less physically active and in the lowest BMI
fifths (Supplementary Table 2, available as Supplementary
data at IJE online). For most of these differences, the
magnitudes were small.
In the overall cohort, zWHR was only weakly corre-
lated with zBMI (partial correlation¼ 0.15), whereas zWC
and zWHtR were strongly correlated with zBMI (Table 2).
When examined in the four strata, the patterns were
broadly similar.
Differences between BMI and WHR in their
associations with glycaemic and BP outcomes
Values of fasting glucose (Figure 2), SBP (Figure 3) and
DBP (Figure 4) were higher with increasing z-score fifths of
both BMI and WHR, as were prevalences of diabetes
(Figure 5) and hypertension (Figure 6). There was no
evidence of a departure from a linear trend. Table 3 shows
differences in means for continuous outcomes and odds
ratios for binary outcomes for each increase in z-score
fifths of BMI/WHR, with additional adjustment for all
potential confounders. There were positive associations of
both zBMI and zWHR with fasting glucose, diabetes, SBP,
DBP and hypertension. These associations did not change
notably with additional adjustment for smoking status,
alcohol intake, wealth or physical activity level. The
magnitudes of association for all outcomes were larger
(nearly double for continuous outcomes) for zBMI
compared with zWHR.
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Table 1. Characteristics of the whole study population and in women and men, rural and urban resident Malawian adults
Rural Residents Urban Residents
Total
N¼ 27 880 (%)
Females
n¼ 7528 (27%)
Males
n¼ 5849 (21%)
Females
n¼ 9290 (33%)
Males
n¼ 5213 (19%)
Sex N (%) Women 16 818 (60.3) – – – –
Men 11 062 (39.7) – – – –
Residence N (%) Rural 13 377 (48.0) – – – –
Urban 14 503 (52.0) – – – –
Age Mean (6SD) 35.9 (15.1) 39.4 (16.5) 38.3 (16.5) 33.0 (12.6) 33.5 (13.8)
Wealth fifthsa N (%) 1 (<£102) 4988 (17.9) 1960 (26.0) 1425 (24.4) 1073 (11.5) 530 (10.2)
2 (£102-£158) 5998 (21.5) 2388 (31.7) 1918 (32.8) 1107 (11.9) 585 (11.2)
3 (£158-£307) 5346 (19.2) 1483 (19.7) 1163 (19.9) 1773 (19.1) 927 (17.8)
4 (£307-£583) 6468 (23.2) 1193 (15.8) 952 (16.3) 2772 (29.8) 1551 (29.7)
5 (>£583) 4851 (17.4) 504 (6.7) 391 (6.7) 2435 (26.2) 1521 (29.2)
Missing 229 (0.8) 0 (0) 0 (0) 130 (1.4) 99 (1.9)
Smoking status N (%) Never 26 583 (95.3) 7504 (99.7) 4798 (82.0) 9230 (99.3) 4339 (83.2)
Ex-smoker 712 (2.5) 10 (0.1) 262 (4.5) 38 (0.4) 402 (7.7)
Light (<6 cigs/day) 810 (2.9) 12 (0.2) 485 (98.3) 15 (0.2) 298 (5.7)
Heavy (6 cigs/day) 487 (1.7) 2 (0.03) 304 (5.2) 7 (0.1) 174 (3.3)
Alcohol intake
N (%)
None in past year 22 627 (81.2) 7251 (96.3) 3394 (58.0) 8709 (93.7) 3273 (62.8)
Light (<8 units/wk) 4015 (14.4) 266 (3.5) 1966 (33.6) 510 (5.5) 1273 (24.4)
Moderate (8-21 units/wk) 990 (3.5) 11 (0.1) 386 (6.6) 64 (0.7) 529 (10.2)
Heavy (>21 units/wk) 248 (0.9) 0 (0.0) 103 (1.8) 7 (0.1) 138 (2.6)
Physical activity
level N (%)
Low (<4 METs/day) 1044 (3.7) 182 (2.4) 245 (4.2) 186 (2.0) 431 (8.3)
Moderate (4-7 METs/day) 2831 (10.2) 348 (4.6) 765 (13.1) 596 (6.4) 1122 (21.5)
High (>7 METs/day) 24 005 (86.1) 6998 (93.0) 4839 (82.7) 8508 (91.6) 3660 (70.2)
Previous hypertension
diagnosis
N (%)
No 25 354 (90.9) 6879 (91.4) 5624 (96.1) 8047 (86.6) 4804 (92.1)
Yes, on medication 1184 (4.2) 380 (5.0) 127 (2.2) 497 (5.4) 180 (3.5)
Yes, not on medication 1342 (4.8) 269 (3.6) 98 (1.7) 746 (8.0) 229 (4.4)
Systolic BP
N (%)
Mean (6SD) 122.8 (17.6) 119.6 (19.3) 124.3 (15.6) 121.7 (17.6) 127.8 (15.7)
Missing 20 (0.07) 8 (0.1) 2 (0.03) 8 (0.1) 2 (0.04)
Diastolic BP
N (%)
Mean (6SD) 73.6 (10.8) 73.1 (10.5) 73.0 (10.3) 74.2 (11.0) 74.0 (11.5)
Missing 19 (0.07) 8 (0.1) 2 (0.03) 7 (0.1) 2 (0.04)
Hypertensive N (%) No 23 790 (85.3) 6430 (85.4) 5060 (86.5) 7947 (85.5) 4353 (83.5)
Yes 4090 (14.7) 1098 (14.6) 789 (13.5) 1343 (14.5) 860 (16.5)
Previous diabetes
diagnosis
No 27 552 (98.8) 7460 (99.1) 5808 (99.3) 9155 (98.5) 5129 (98.4)
Yes, on medication 225 (0.8) 46 (0.6) 33 (0.6) 91 (1.0) 55 (1.1)
Yes, not on medication 103 (0.4) 22 (0.3) 8 (0.1) 44 (0.5) 29 (0.6)
Fasting blood
glucose N (%)
Mean (6SD) 4.8 (1.3) 4.7 (1.2) 4.7 (1.2) 4.8 (1.3) 4.8 (1.3)
Missing 4726 (16.9) 823 (10.9) 844 (14.4) 1777 (19.1) 1282 (24.6)
Diabetic N (%) No 22 634 (81.2) 6588 (87.5) 4925 (84.2) 7307 (78.6) 3814 (73.2)
Yes 558 (2.0) 123 (1.6) 84 (1.4) 219 (2.4) 132 (2.5)
Missing 4688 (16.8) 817 (10.9) 840 (14.4) 1764 (19.0) 1267 (24.3)
Weight N (%) Median (IQR) 58.2 (52.0, 66.1) 54.4 (48.7, 61.8) 57.8 (53.0, 63.6) 59.8 (52.5, 70.4) 60.9 (55.6, 68.0)
Missing 34 (0.1) 15 (0.2) 13 (0.2) 5 (0.1) 1 (0.02)
BMI N (%) Median (IQR) 22.4 (20.4, 25.4) 22.6 (20.4, 25.3) 21.2 (19.8, 22.9) 24.3 (21.5, 28.3) 21.7 (20.1, 24.0)
Missing 56 (0.2) 31 (0.4) 15 (0.3) 8 (0.1) 2 (0.04)
WC N (%) Median (IQR) 77.3 (72.3, 85.0) 79.1 (73.6, 86.4) 76.1 (72.5, 81.0) 78.0 (71.5, 87.2) 76.0 (72.0, 83.0)
Missing 35 (0.1) 18 (0.2) 10 (0.2) 6 (0.1) 1 (0.02)
WHR N (%) Median (IQR) 0.84 (0.80, 0.88) 0.85 (0.81, 0.90) 0.85 (0.82, 0.89) 0.80 (0.76, 0.85) 0.84 (0.80, 0.88)
Missing 43 (0.1) 21 (0.3) 12 (0.2) 9 (0.1) 1 (0.02)
WHtR N (%) Median (IQR) 0.48 (0.45, 0.54) 0.51 (0.47, 0.56) 0.46 (0.44, 0.49) 0.50 (0.46, 0.56) 0.46 (0.43, 0.50)
Missing 59 (0.2) 33 (0.4) 15 (0.3) 9 (0.1) 2 (0.04)
Cigs, cigarettes; wk, week; MET, metabolic equivalent; IQR, interquartile range.
aEquivalent values in Malawian Kwacha are<97 000MWK, 97 000–150 500MWK, 150 500–291 500MWK, 291 500–553 500MWK and>553 500 for each fifth.
International Journal of Epidemiology, 2018, Vol. 47, No. 3 891
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/article-abstract/47/3/887/4965904 by U
niversity of G
lasgow
 user on 12 M
arch 2020
Associations of BMI and WHR with glycaemic and
BP outcomes in gender and area of residence
strata
There were positive linear associations of zBMI and
zWHR with most outcomes in all four strata—rural
women, rural men, urban women, urban men—but these
stratified results highlighted notable differences in magni-
tudes of associations between rural and urban residents
and between women and men (Table 4).
For the associations with difference in mean fasting
glucose and odds of diabetes, positive associations were
generally stronger for zBMI than zWHR, but the
differences between these two adiposity measurements
were less marked in urban residents. For men, the increase
in odds of diabetes for each greater fifth of adiposity was
greater for zWHR than zBMI (Table 4). The magnitudes of
association of both zBMI and zWHR with fasting glucose
and odds of diabetes were greater in urban than rural resi-
dents. For the odds of diabetes, the magnitudes of associ-
ation with zBMI were higher in women compared with
men, but the associations with zWHR were higher in men.
For the differences in mean SBP and DBP and odds of
hypertension, the associations were also stronger for zBMI
than for zWHR (Table 4). zWHR was negatively associated
with SBP in rural female residents; all other associations
were positive. As with glycaemic outcomes, associations of
the adiposity measures with BP were stronger in urban than
rural residents. However, adiposity was more strongly asso-
ciated with BP outcomes in men than in women.
For the associations with zBMI, there was statistical
evidence that associations of SBP and diabetes differed by
gender and that associations of fasting glucose and DBP
differed by area of residence. The association between zBMI
and hypertension differed by both gender and area of resi-
dence. Associations with WHR and SBP, DBP, diabetes and
hypertension differed by both gender and area of residence.
When participants who self-reported a previous diagnosis of
hypertension but did not have elevated BPs were excluded
from fully adjusted stratified analyses, there was little to no
difference in the odds of hypertension (Supplementary
Table 6, available as Supplementary data at IJE online).
When fifths of zBMI and zWHR were determined within
the four strata of area of residence and gender, there were
only minor decreases in the difference in mean systolic
BP, diastolic BP and odds ratio of diabetes among men—
especially rural male residents (Supplementary Table 7,
available as Supplementary data at IJE online). With adjust-
ment (in addition to all other confounders) for the number
of live births in women, results are not materially affected
compared with those without adjustment (Supplementary
Table 8, available as Supplementary data at IJE online).
Supplementary Tables 3 and 5 (available as Supplementary
data at IJE online) show the results for zWC and zWHtR. For
most outcomes, associations of both zWC and zWHtR were
similar in magnitude to those of zBMI (i.e. they were stronger
than those for zWHR). The two exceptions were that zWHtR
was associated with systolic blood pressure with a magnitude
that was similar to that of zWHtR and weaker than
zBMI, and both zWC and zWHtR were associated with dia-
betes with a magnitude that was somewhat stronger than
zBMI.
Discussion
In this large study of Malawian adults, we have shown
positive linear associations of BMI and WHR with adverse
glycaemic and blood pressure outcomes in the overall
cohort, and also within strata of female and male rural
residents and female and male urban residents. In the
overall cohort, and for most strata, the associations were
stronger across z-score fifths for BMI than they were for
WHR, suggesting that BMI might be a more useful meas-
ure of cardiometabolic risk than WHR in this population.
Table 2. Age-adjusted partial correlations of anthropometric
measurements
zBMI zWC zWHR zWHtR
Whole cohort N ¼ 27 880
zBMI 1
zWC 0.83 1
zWHR 0.15 0.53 1
zWHtR 0.84 0.92 0.49 1
Rural females N ¼ 7528
zBMI 1
zWC 0.85 1
zWHR 0.24 0.6 1
zWHtR 0.84 0.95 0.63 1
Rural males N ¼ 5849
zBMI 1
zWC 0.82 1
zWHR 0.31 0.58 1
zWHtR 0.83 0.89 0.62 1
Urban females N ¼ 9290
zBMI 1
zWC 0.86 1
zWHR 0.26 0.58 1
zWHtR 0.86 0.96 0.61 1
Urban males N ¼ 5213
zBMI 1
zWC 0.79 1
zWHR 0.33 0.65 1
zWHtR 0.81 0.92 0.67 1
zBMI, z-score, age-standardized body mass index; zWC, z-score, age-stand-
ardized waist-circumference; zWHR, z-score, age-standardized waist-to-hip
ratio; zWHtR, z-score, age-standardized waist-to-height ratio.
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Magnitudes of association differed by gender and area
of residence, such that for the associations of BMI and
WHR with glycaemic outcomes, the associations were
stronger in urban than rural residents, with little difference
between women and men. The associations of zBMI and
zWHR with BP-related outcomes were also stronger in
urban than rural residents and we observed stronger asso-
ciations in men compared with women for BP-related
outcomes. These findings changed little after adjustment
for smoking status, alcohol intake, physical activity and
wealth, or with additional adjustment for number of live
births. We did not adjust for breastfeeding as the vast ma-
jority (98%) of women in this population, as in other SSA
countries, have breastfed and therefore this characteristic
cannot explain the association of adiposity with cardiome-
tabolic outcomes in these populations.
Figure 2. Mean fasting glucose per fifth of zBMI and zWHR in participants without diabetes (N¼ 22 906); zBMI, z-score age-standardized body mass
index; zWHR, z-score age-standardized waist-to-hip ratio. Dots/triangles and first numerical results are mean fasting glucose (mmol/l); ends of vertical
lines and numerical results in brackets represent the 95% confidence interval of the percentages.
Figure 3. Mean systolic blood pressure per fifth of zBMI and zWHR in participants without hypertension (N¼ 26 682); zBMI, z-score age-standardized
body mass index; zWHR, z-score age-standardized waist-to-hip ratio. Dots/triangles and first numerical results are mean systolic blood pressure
(mmHg); ends of vertical lines and numerical results in brackets represent the 95% confidence interval of the percentages.
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The greater positive magnitude of association of BMI
and WHR with glycaemic and BP outcomes in urban resi-
dents is particularly of concern, given that increases in
rates of obesity and overweight are greater in urban than
rural areas. Our finding of more adverse distributions of
cardiovascular risk factors in urban combined with rural
residents is consistent with findings from studies in
several other SSA countries.11,13 However, few studies
have examined the associations of adiposity with risk fac-
tors as we have done here, and to our knowledge only one
previous study has noted differences in association magni-
tudes between rural and urban residents. In the
Cameroonian study, there appeared to be a positive asso-
ciation of BMI with high fasting glucose, insulin,
Figure 4. Mean diastolic blood pressure per fifth of zBMI and zWHR in participants without hypertension (N¼ 26 683); zBMI, z-score age-standardized
body mass index; zWHR, z-score age-standardized waist-to-hip ratio. Dots/triangles and first numerical results are mean diastolic blood pressure
(mmHg); ends of vertical lines and numerical results in brackets represent the 95% confidence interval of the percentages.
Figure 5. Percentage with diabetes per fifth of zBMI and zWHR (N¼ 23 148); zBMI, z-score age-standardized body mass index; zWHR, z-score age-
standardized waist-to-hip ratio. Dots/triangles and first numerical results are percentage with diabetes; ends of vertical lines and numerical results in
brackets represent the 95% confidence interval of the percentages. Diabetes was defined as having any of the following: fasting glucose7.0mmol/l,
currently taking antidiabetic medication or a self-report of a previous diabetes diagnosis.
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triglycerides and BP in urban residents (N¼ 959), but an
inverse association in rural residents (N¼669), whereas
we saw positive linear associations in both groups but
these were weaker in rural residents.8 That study was
conducted over 20 years ago, when levels of overweight
and obesity were much lower than currently in SSA.
Nonetheless the possibility, from that study and ours,
that greater adiposity has a stronger positive association
with adverse cardiometabolic health in urban than in
rural areas is concerning, as urbanization continues at
pace in SSA. The already stretched health services in these
countries could struggle to cope with a substantial burden
of cardiometabolic illness.
Why associations are stronger in urban compared with
rural populations is unclear. In our study, the rural popula-
tions are predominantly subsistence farmers and/or from
fishing communities, and hence they and previous gener-
ations have high levels of physical activity and a diet that is
largely fruit, vegetable and fish based. Urban residents are
likely to be less active, and in urban areas there is a greater
availability of processed food and lower availability of
fresh fruit and vegetables. However, for these to contribute
to the differences in associations that we observe (as
opposed to differences in distributions) would imply some
aspect of diet or physical activity interacting with adiposity
in terms of its association with blood pressure and
glycaemic outcomes, which has not been observed in
high-income populations. The factors that might explain
the greater association of adiposity with outcomes in urban
compared with rural residents, which we and a previous
study from Cameroon have observed, need further
mechanistic studies.
A priori we considered WHR to be the most appropri-
ate measure of central adiposity that was distinct from
total adiposity as reflected in BMI. However, we also
present the findings for WC and WHtR in Supplementary
materials (available as Supplementary data at IJE online).
Given the strong correlations of these measures with BMI,
it is not surprising that they have similar magnitudes of as-
sociations with outcomes to those seen for BMI (and hence
stronger than those seen for WHR). Distinguishing the
relative contributions of BMI, WC and WHtR to cardio-
metabolic outcomes in SSA populations will require ex-
tremely large numbers because of problems of co-linearity
between these measures.
The key strengths of this study include large sample
size, inclusion of both urban and rural residents, and high
quality collection of data which included fasting blood
samples, which enabled us to assess associations with fast-
ing glucose and diabetes. A key limitation is the cross-
sectional nature of this study and hence the possibility that
our findings are wholly, or partly, due to reverse causality
and/or residual confounding. Evidence from Mendelian
randomization and randomized control trials (both less
prone to reverse causality or confounding) in European ori-
ginal participants suggests that greater adiposity increases
risks of diabetes and hypertension, and it would seem
reasonable to assume that is the case here.4–6,14,15
Despite finding higher levels of overweight and obesity in
urban compared with rural residents, the distributions of
Figure 6. Percentage with hypertension per fifth of zBMI and zWHR (N¼ 27 880); zBMI, z-score age-standardized body mass index; zWHR, z-score
age-standardized waist-to-hip ratio. Dots/triangles and first numerical results are percentages with hypertension; ends of vertical lines and numerical
results in brackets represent the 95% confidence interval of the percentages. Hypertension was defined as having either SBP140mmHg or
DBP90mmHg or were on antihypertensive medication.
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physical activity, smoking and alcohol were similar in the
two groups. These lifestyle factors are self-reported and the
categories available are quite broad, and therefore important
differences might have been missed. It is possible that
misclassification resulting from self-report explains some of
the differences between gender and residence strata.
Furthermore, we do not have information on dietary intake,
which we anticipate is different between rural and urban
residents. Future large-scale studies in SSA populations
which are able to measure physical activity objectively
(with accelerometers) and dietary intake would be valuable.
Whereas there were very few missing data for the vast
majority of measurements, 17% did not have a valid fasting
blood glucose sample and therefore were excluded from
analyses with glycaemic-related conditions. Those without
fasting glucose differed from those with it, but the magni-
tudes of these differences were small, and we adjusted for
these characteristics. Our results would be biased if, in
those without fasting glucose, associations were markedly
different from those found here in participants with fasting
glucose, even after taking into account age, gender, rural/
urban residence, smoking status, alcohol intake, physical
activity level and wealth. Although we have no way of rul-
ing this out, we cannot see why this would be the case.
In conclusion, our novel findings, which to our know-
ledge have not been previously explored in a SSA popula-
tion, suggest that BMI is a useful measure for identifying
those at risk of adverse cardiometabolic outcomes in SSA.
Our results highlight the potential for major increases in
adverse cardiometabolic health in urban areas of SSA, un-
less concerted efforts for preventing increases in adiposity
are successfully introduced. Although this might also apply
to other low-income countries in the SSA region, there is
also evidence of increasing risk in rural communities in
higher-income countries such as South Africa,16–18 and so
any interventions should not disadvantage rural residents.
Supplementary data
Supplementary data are available at IJE online.
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